Efficacy of Bisphosphonates for the Treatment of Osteoporosis in Patients with Multiple Sclerosis

Objective: The aim of this study was to evaluate the effectiveness of bisphosphonates in osteoporotic patients with multiple sclerosis. Materials and Methods: Patients with multiple sclerosis, who were started on treatment with a diagnosis of osteoporosis, at the Department of Physical Medicine an...

Full description

Bibliographic Details
Published in:	Türk Osteoporoz Dergisi
Main Authors:	İlke Coşkun Benlidayı, Sibel Başaran, Ahmet Evlice, Miray Erdem, Meltem Demirkıran
Format:	Article
Language:	English
Published:	Turkish Society of Osteoporosis 2015-08-01
Subjects:	Bisphosphonate multiple sclerosis osteoporosis
Online Access:	http://www.turkosteoporozdergisi.org/article_8979/Efficacy-Of-Bisphosphonates-For-The-Treatment-Of-Osteoporosis-In-Patients-Withmultiple-Sclerosis

Similar Items

Teriparatide Treatment Following Osteoporotic Hip Fracture in a Male Patient with Multiple Sclerosis and Current Recommendations
by: Sibel Başaran, et al.
Published: (2015-12-01)

Outcomes of Treatment in Patients with Elderly Postmenopausal Osteoporosis: Comparision of Oral and Parenteral Bisphosphonates
by: Ahmet Aslan, et al.
Published: (2018-08-01)

Development of Osteonecrosis of the Jaw in a Patient Receiving Oral Bisphosphonates for Osteoporosis: A Case Report
by: Sina Esmaeilzadeh, et al.
Published: (2014-08-01)

Efficacy of Alendronate and Cholecalciferol Combination in the Treatment of Osteoporosis in Patients with Chronic Viral Hepatitis Receiving Antiviral Therapy: Report of Two Cases
by: İlke Coşkun Benlidayı, et al.
Published: (2015-08-01)

Bisphosphonates in the Management of Patients with Postmenopausal Osteoporosis; Back to the Future
by: Socrates E. Papapoulos, et al.
Published: (2025-07-01)

Long-term Treatment with Bisphosphonates and Their Side Effects in Postmenopausal Osteoporosis - Review
by: Merih Sarıdoğan, et al.
Published: (2010-12-01)

The use of bisphosphonates for the treatment and prevention of osteoporosis
by: O. A. Nikitinskaya, et al.
Published: (2022-08-01)

glucocorticoid osteoporosis; osteoporotic fracture; bisphosphonates; FRAX algorithm
by: Natalia Vladimirovna Toroptsova, et al.
Published: (2013-12-01)

Efficacy and safety of abaloparatide, denosumab, teriparatide, oral bisphosphonates, and intravenous bisphosphonates in the treatment of male osteoporosis: a systematic review and Bayesian network meta-analysis
by: Liangshi Chen, et al.
Published: (2025-04-01)

Long-term consequences of osteoporosis therapy with bisphosphonates
by: Bárbara Gehrke, et al.
Published: (2023-11-01)

The efficacy and safety of denosumab in postmenopausal women with osteoporosis previously treated with bisphosphonates: A review
by: Yilin Zhu, et al.
Published: (2020-05-01)

Modern principles for the diagnosis and treatment of postmenopausal osteoporosis: a focus on bisphosphonates
by: I. B. Belyaeva, et al.
Published: (2020-08-01)

The therapeutic effect to eldecalcitol + bisphosphonate is superior to bisphosphonate alone in the treatment of osteoporosis: a meta-analysis
by: Zaoqian Zheng, et al.
Published: (2020-09-01)

Search for genetic markers determining the efficiency of therapy with bisphosphonates in Russian women with postmenopausal osteoporosis: A pilot study
by: M. Yu. Krylov, et al.
Published: (2016-10-01)

Efficacy and safety of bisphosphonates in pediatric glucocorticoid-induced osteoporosis: a meta-analysis and pharmacovigilance study
by: Xiaolin Xu, et al.
Published: (2025-07-01)

Health-related quality of life of men with primary osteoporosis and its changes after bisphosphonates treatment
by: Di-chen Zhao, et al.
Published: (2023-04-01)

Bone Quality and Fractures in Women With Osteoporosis Treated With Bisphosphonates for 1 to 14 Years
by: Hartmut H Malluche, et al.
Published: (2021-11-01)

Safety and efficacy of bisphosphonates in thalassemia patients with osteopenia/osteoporosis
by: Sujata Sharma, et al.
Published: (2023-04-01)

Awareness and Knowledge Levels of Osteoporosis in Patients with Multiple Sclerosis
by: Ali Karakaş, et al.
Published: (2022-08-01)

Bisphosphonate drug holidays: Can we recommend currently?
by: Vishal R Tandon, et al.
Published: (2014-01-01)

The Effects of Bisphosphonate Therapy on Upper Gastrointestinal Tract in Postmenopausal Women: A Preliminary Report
by: Zeliha Ünlü, et al.
Published: (2002-09-01)

Efficacy and safety of denosumab and teriparatide versus oral bisphosphonates to treat postmenopausal osteoporosis: a systematic review and meta-analysis
by: Jia Yang, et al.
Published: (2024-09-01)

The efficacy of bisphosphonates for osteoporosis in young Cushing’s disease patients with biochemical remission: a retrospective cohort study
by: Quanya Sun, et al.
Published: (2024-06-01)

Atypical femur fractures associated with chronic bisphosphonates use: A case series with 66 patients
by: Guilherme Guadagnini Falotico, et al.
Published: (2022-11-01)

Case Report: single low-dose of denosumab as a trigger of MRONJ development in a patient with osteoporosis after bisphosphonate therapy
by: Dávid Száraz, et al.
Published: (2024-12-01)

Comparative efficacy of teriparatide and bisphosphonates or denosumab vs. teriparatide monotherapy in osteoporosis: a meta-analysis
by: Huan Jin, et al.
Published: (2025-05-01)

Retrospective analysis of 27 cases of bisphosphonate-related osteonecrosis of the jaw treated surgically or nonsurgically
by: Shin-Yu Lu, et al.
Published: (2014-06-01)

Cardioprotective effects of alendronate bisphosphonate in patients with ischemic heart disease associated with type 2 diabetes mellitus and osteoporosis
by: S. N. Shilov, et al.
Published: (2021-05-01)

FARNESYL DIPHOSPHATE SYNTHASE (FDRS) AND GERANYLGERANYL DIPHOSPHATE SYNTHASE (GGSP1) GENE POLYMORPHISMS AND EFFICIENCY OF THERAPY WITH BISPHOSPHONATES IN RUSSIAN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS: A PILOT STUDY
by: M. Yu. Krylov, et al.
Published: (2016-03-01)

Gradual, but Not Sudden, Dose-Dependent Increase of ONJ Risk With Bisphosphonate Exposure: A Nationwide Cohort Study in Women With Osteoporosis
by: Jung-Hyun Park, et al.
Published: (2021-12-01)

Fibrous Dysplasia in a Child Patient Treated with Bisphosphonates
by: R. Hodan, et al.
Published: (2008-12-01)

Changes in the utilization of osteoporosis drugs after the 2010 FDA bisphosphonate drug safety communication
by: Bander Balkhi, et al.
Published: (2018-02-01)

Drug Holiday in Osteoporosis
by: Annil Mahajan, et al.
Published: (2024-07-01)

Drug Holiday in Osteoporosis
by: Annil Mahajan, et al.
Published: (2024-07-01)

Effect of bisphosphonate on bone microstructure, mechanical strength in osteoporotic rats by ovariectomy
by: Yuzhu Wang, et al.
Published: (2024-09-01)

Additional effects of herbal medicine combined with bisphosphonates for primary osteoporosis: a systematic review and meta-analysis
by: Young-Seo Yoo, et al.
Published: (2024-09-01)

Bisophosphonates in the treatment of osteoporosis in women with breast cancer
by: Joanna Wolska
Published: (2019-09-01)

The problem of low adherence to antiresorptive therapy with bisphosphonates: solutions
by: O. V. Yakushevskaya
Published: (2022-01-01)

The Effects of Bisphosphonates Used Continually or Intermittently on Fractures, Bone Mineral Density and Biochemical Parameters in Osteoporotic Patients - Original Investigation
by: Alev Çevikol, et al.
Published: (2010-04-01)

Current treatment of osteoporosis
by: Subramanian Nallasivan
Published: (2019-01-01)